Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

International typing study of Clostridium difficile.

Manzo CE, Merrigan MM, Johnson S, Gerding DN, Riley TV, Silva J Jr, Brazier JS; International Clostridium difficile Study Group.

Anaerobe. 2014 Aug;28:4-7. doi: 10.1016/j.anaerobe.2014.04.005. Epub 2014 Apr 21.

PMID:
24768986
2.

Clostridium difficile: the anaerobe that made the grade.

Brazier JS.

Anaerobe. 2012 Apr;18(2):197-9. doi: 10.1016/j.anaerobe.2011.12.021. Epub 2012 Jan 25.

PMID:
22293217
3.

Extended multilocus variable-number tandem-repeat analysis of Clostridium difficile correlates exactly with ribotyping and enables identification of hospital transmission.

Manzoor SE, Tanner HE, Marriott CL, Brazier JS, Hardy KJ, Platt S, Hawkey PM.

J Clin Microbiol. 2011 Oct;49(10):3523-30. doi: 10.1128/JCM.00546-11. Epub 2011 Aug 17.

4.

Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measures.

Aldeyab MA, Devine MJ, Flanagan P, Mannion M, Craig A, Scott MG, Harbarth S, Vernaz N, Davies E, Brazier JS, Smyth B, McElnay JC, Gilmore BF, Conlon G, Magee FA, Elhajji FW, Small S, Edwards C, Funston C, Kearney MP.

Infect Control Hosp Epidemiol. 2011 Mar;32(3):210-9. doi: 10.1086/658333.

PMID:
21460505
5.

New types of toxin A-negative, toxin B-positive strains among clinical isolates of Clostridium difficile in Australia.

Elliott B, Squire MM, Thean S, Chang BJ, Brazier JS, Rupnik M, Riley TV.

J Med Microbiol. 2011 Aug;60(Pt 8):1108-11. doi: 10.1099/jmm.0.031062-0. Epub 2011 Mar 10.

PMID:
21393460
6.

Clostridium difficile infection in Europe: a hospital-based survey.

Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, Monnet DL, van Dissel JT, Kuijper EJ; ECDIS Study Group.

Lancet. 2011 Jan 1;377(9759):63-73. doi: 10.1016/S0140-6736(10)61266-4.

PMID:
21084111
7.

An outbreak case of Clostridium difficile-associated diarrhea among elderly inpatients of an intensive care unit of a tertiary hospital in Rio de Janeiro, Brazil.

Balassiano IT, Dos Santos-Filho J, de Oliveira MP, Ramos MC, Japiassu AM, Dos Reis AM, Brazier JS, de Oliveira Ferreira E, Domingues RM.

Diagn Microbiol Infect Dis. 2010 Dec;68(4):449-55. doi: 10.1016/j.diagmicrobio.2010.07.017. Epub 2010 Sep 29.

PMID:
20884155
8.

Detection of cross-infection associated to a Brazilian PCR-ribotype of Clostridium difficile in a university hospital in Rio de Janeiro, Brazil.

Balassiano IT, dos Santos-Filho J, Vital-Brazil JM, Nouér SA, Souza CR, Brazier JS, Ferreira Ede O, Domingues RM.

Antonie Van Leeuwenhoek. 2011 Feb;99(2):249-55. doi: 10.1007/s10482-010-9483-8. Epub 2010 Jul 11.

PMID:
20623188
9.

Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease.

Wultańska D, Banaszkiewicz A, Radzikowski A, Obuch-Woszczatyński P, Młynarczyk G, Brazier JS, Pituch H, van Belkum A.

Eur J Clin Microbiol Infect Dis. 2010 Oct;29(10):1265-70. doi: 10.1007/s10096-010-0997-9. Epub 2010 Jun 26.

10.

First report of Parabacteroides goldsteinii bacteraemia in a patient with complicated intra-abdominal infection.

Awadel-Kariem FM, Patel P, Kapoor J, Brazier JS, Goldstein EJ.

Anaerobe. 2010 Jun;16(3):223-5. doi: 10.1016/j.anaerobe.2010.01.001. Epub 2010 Feb 6.

PMID:
20139022
11.

Correlation of multidrug resistance, toxinotypes and PCR ribotypes in Clostridium difficile isolates from Kuwait.

Jamal WY, Rotimi VO, Grubesic A, Rupnik M, Brazier JS, Duerden BI.

J Chemother. 2009 Nov;21(5):521-6.

PMID:
19933043
12.

Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007.

Cheknis AK, Sambol SP, Davidson DM, Nagaro KJ, Mancini MC, Hidalgo-Arroyo GA, Brazier JS, Johnson S, Gerding DN.

Anaerobe. 2009 Dec;15(6):230-3. doi: 10.1016/j.anaerobe.2009.09.001. Epub 2009 Sep 6.

PMID:
19737618
13.

First isolation of Clostridium difficile PCR ribotype 027 from a patient with severe persistent diarrhoea in Hungary.

Terhes G, Urbán E, Konkoly-Thege M, Székely E, Brazier JS, Kuijper EJ, Nagy E.

Clin Microbiol Infect. 2009 Sep;15(9):885-6. doi: 10.1111/j.1469-0691.2009.02807.x.

14.

Comparison of molecular typing methods applied to Clostridium difficile.

Kuijper EJ, van den Berg RJ, Brazier JS.

Methods Mol Biol. 2009;551:159-71. doi: 10.1007/978-1-60327-999-4_13. Review.

PMID:
19521874
15.

Application of multiple-locus variable-number tandem-repeat analysis to determine clonal spread of toxin A-negative Clostridium difficile in a general hospital in Buenos Aires, Argentina.

Goorhuis A, Legaria MC, van den Berg RJ, Harmanus C, Klaassen CH, Brazier JS, Lumelsky G, Kuijper EJ.

Clin Microbiol Infect. 2009 Dec;15(12):1080-6. doi: 10.1111/j.1469-0691.2009.02759.x. Epub 2009 May 11.

16.

Equine colitis X associated with infection by Clostridium difficile NAP1/027.

Songer JG, Trinh HT, Dial SM, Brazier JS, Glock RD.

J Vet Diagn Invest. 2009 May;21(3):377-80.

PMID:
19407094
17.

lktA-encoded leukotoxin is not a universal virulence factor in invasive Fusobacterium necrophorum infections in animals and man.

Ludlam HA, Milner NJ, Brazier JS, Davies IH, Perry K, Marriott RK, Donachie L, Curran MD.

J Med Microbiol. 2009 Apr;58(Pt 4):529-30. doi: 10.1099/jmm.0.005231-0. No abstract available.

PMID:
19273652
18.

Characterization of Clostridium difficile strains isolated from immunosuppressed inpatients in a hospital in Rio de Janeiro, Brazil.

Balassiano IT, Miranda KR, Boente RF, Pauer H, Oliveira IC, Santos-Filho J, Amorim EL, Caniné GA, Souza CF, Gomes MZ, Ferreira EO, Brazier JS, Domingues RM.

Anaerobe. 2009 Jun;15(3):61-4. doi: 10.1016/j.anaerobe.2008.12.007. Epub 2009 Jan 13.

PMID:
19154793
19.

Increased number of Clostridium difficile infections and prevalence of Clostridium difficile PCR ribotype 001 in southern Germany.

Borgmann S, Kist M, Jakobiak T, Reil M, Scholz E, von Eichel-Streiber C, Gruber H, Brazier JS, Schulte B.

Euro Surveill. 2008 Dec 4;13(49). pii: 19057.

20.

Distribution and antimicrobial susceptibility patterns of Clostridium difficile PCR ribotypes in English hospitals, 2007-08.

Brazier JS, Raybould R, Patel B, Duckworth G, Pearson A, Charlett A, Duerden BI; HPA Regional Microbiology Network.

Euro Surveill. 2008 Oct 9;13(41). pii: 19000.

21.

Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008.

Kuijper EJ, Barbut F, Brazier JS, Kleinkauf N, Eckmanns T, Lambert ML, Drudy D, Fitzpatrick F, Wiuff C, Brown DJ, Coia JE, Pituch H, Reichert P, Even J, Mossong J, Widmer AF, Olsen KE, Allerberger F, Notermans DW, Delmée M, Coignard B, Wilcox M, Patel B, Frei R, Nagy E, Bouza E, Marin M, Akerlund T, Virolainen-Julkunen A, Lyytikäinen O, Kotila S, Ingebretsen A, Smyth B, Rooney P, Poxton IR, Monnet DL.

Euro Surveill. 2008 Jul 31;13(31). pii: 18942.

22.

Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe.

Spigaglia P, Barbanti F, Mastrantonio P, Brazier JS, Barbut F, Delmée M, Kuijper E, Poxton IR; European Study Group on Clostridium difficile (ESGCD).

J Med Microbiol. 2008 Jun;57(Pt 6):784-9. doi: 10.1099/jmm.0.47738-0.

PMID:
18480338
23.

Clostridium difficile: from obscurity to superbug.

Brazier JS.

Br J Biomed Sci. 2008;65(1):39-44. Review.

PMID:
18476496
24.

Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe.

Kuijper EJ, Coignard B, Brazier JS, Suetens C, Drudy D, Wiuff C, Pituch H, Reichert P, Schneider F, Widmer AF, Olsen KE, Allerberger F, Notermans DW, Barbut F, Delmée M, Wilcox M, Pearson A, Patel BC, Brown DJ, Frei R, Akerlund T, Poxton IR, Tüll P.

Euro Surveill. 2007 Jun 1;12(6):E1-2.

PMID:
17991399
25.

Coincidence of bft and cfiA genes in a multi-resistant clinical isolate of Bacteroides fragilis.

Terhes G, Brazier JS, Sóki J, Urbán E, Nagy E.

J Med Microbiol. 2007 Oct;56(Pt 10):1416-8. No abstract available.

PMID:
17893185
26.

Distribution of Clostridium difficile PCR ribotype 027 in British hospitals.

Brazier JS, Patel B, Pearson A.

Euro Surveill. 2007 Apr 26;12(4):E070426.2. No abstract available.

27.

Molecular characterization and antimicrobial susceptibility patterns of Clostridium difficile strains isolated from hospitals in south-east Scotland.

Mutlu E, Wroe AJ, Sanchez-Hurtado K, Brazier JS, Poxton IR.

J Med Microbiol. 2007 Jul;56(Pt 7):921-9.

PMID:
17577057
28.

Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves, and other species.

Keel K, Brazier JS, Post KW, Weese S, Songer JG.

J Clin Microbiol. 2007 Jun;45(6):1963-4. Epub 2007 Apr 11.

29.

Genetic analysis of mechanisms of multidrug resistance in a clinical isolate of Bacteroides fragilis.

Pumbwe L, Wareham DW, Aduse-Opoku J, Brazier JS, Wexler HM.

Clin Microbiol Infect. 2007 Feb;13(2):183-189. doi: 10.1111/j.1469-0691.2006.01620.x.

30.

Clostridium difficile PCR ribotypes in calves, Canada.

Rodriguez-Palacios A, Stämpfli HR, Duffield T, Peregrine AS, Trotz-Williams LA, Arroyo LG, Brazier JS, Weese JS.

Emerg Infect Dis. 2006 Nov;12(11):1730-6.

31.

New PCR ribotypes of Clostridium difficile detected in children in Brazil: prevalent types of Clostridium difficile in Brazil.

Alcides AP, Brazier JS, Pinto LJ, Balassiano IT, Boente RF, de Paula GR, Ferreira EO, Avelar KE, Miranda KR, Ferreira MC, Domingues RM.

Antonie Van Leeuwenhoek. 2007 Jul;92(1):53-9. Epub 2007 Jan 25.

PMID:
17252315
32.

Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains.

Stabler RA, Gerding DN, Songer JG, Drudy D, Brazier JS, Trinh HT, Witney AA, Hinds J, Wren BW.

J Bacteriol. 2006 Oct;188(20):7297-305.

33.

Human infections with Fusobacterium necrophorum.

Brazier JS.

Anaerobe. 2006 Aug;12(4):165-72. Epub 2005 Dec 22. Review.

PMID:
16962962
34.
35.

Distribution of Clostridium difficile PCR ribotypes in regions of Hungary.

Terhes G, Brazier JS, Urbán E, Sóki J, Nagy E.

J Med Microbiol. 2006 Mar;55(Pt 3):279-82.

PMID:
16476791
36.

Prevalence and association of PCR ribotypes of Clostridium difficile isolated from symptomatic patients from Warsaw with macrolide-lincosamide-streptogramin B (MLSB) type resistance.

Pituch H, Brazier JS, Obuch-Woszczatynski P, Wultanska D, Meisel-Mikolajczyk F, Luczak M.

J Med Microbiol. 2006 Feb;55(Pt 2):207-13.

PMID:
16434714
37.

Molecular investigation of genetic elements contributing to metronidazole resistance in Bacteroides strains.

Sóki J, Gal M, Brazier JS, Rotimi VO, Urbán E, Nagy E, Duerden BI.

J Antimicrob Chemother. 2006 Feb;57(2):212-20. Epub 2005 Dec 7.

PMID:
16338949
38.

Soft tissue infections caused by spore-forming bacteria in injecting drug users in the United Kingdom.

Brett MM, Hood J, Brazier JS, Duerden BI, Hahné SJ.

Epidemiol Infect. 2005 Aug;133(4):575-82. Review.

41.

Subtyping of Clostridium difficile PCR ribotype 001 by REP-PCR and PFGE.

Northey G, Gal M, Rahmati A, Brazier JS.

J Med Microbiol. 2005 Jun;54(Pt 6):543-7.

PMID:
15888462
42.

Anaerobic sepsis due to multidrug-resistant Bacteroides fragilis: microbiological cure and clinical response with linezolid therapy.

Wareham DW, Wilks M, Ahmed D, Brazier JS, Millar M.

Clin Infect Dis. 2005 Apr 1;40(7):e67-8. Epub 2005 Mar 2.

PMID:
15824978
43.
44.

Outbreak of Clostridium histolyticum infections in injecting drug users in England and Scotland.

Brazier JS, Gal M, Hall V, Morris TE.

Euro Surveill. 2004 Sep;9(9):15-6.

PMID:
15381836
45.

Real-time PCR investigation into the importance of Fusobacterium necrophorum as a cause of acute pharyngitis in general practice.

Aliyu SH, Marriott RK, Curran MD, Parmar S, Bentley N, Brown NM, Brazier JS, Ludlam H.

J Med Microbiol. 2004 Oct;53(Pt 10):1029-35.

PMID:
15358827
46.
47.

Molecular characterization of nitroimidazole resistance in metronidazole-resistant bacteroides species isolated from hospital patients in Kuwait.

Jamal WY, Rotimi VO, Brazier JS, Johny M, Wetieh WM, Duerden BI.

Med Princ Pract. 2004 May-Jun;13(3):147-52.

48.
49.

A European survey of diagnostic methods and testing protocols for Clostridium difficile.

Barbut F, Delmée M, Brazier JS, Petit JC, Poxton IR, Rupnik M, Lalande V, Schneider C, Mastrantonio P, Alonso R, Kuipjer E, Tvede M; ESCMID Study Group on Clostridium difficile (ESGCD).

Clin Microbiol Infect. 2003 Oct;9(10):989-96.

50.

Prevalent PCR ribotypes of clinical and environmental strains of Clostridium difficile isolated from intensive-therapy unit patients in Kuwait.

Rotimi VO, Jamal WY, Mokaddas EM, Brazier JS, Johny M, Duerden BI.

J Med Microbiol. 2003 Aug;52(Pt 8):705-9.

PMID:
12867566

Supplemental Content

Loading ...
Support Center